Ads by Google
More that 1.2 million deaths could be prevented in South Africa over the next five years by accelerating efforts to provide access to antiretroviral therapy.
Tucson Citizen examined a worldwide trial of Merck's antiretroviral drug raltegravir.
AIDS researchers are puzzled at the Summit on HIV Vaccine Research and Development discussing a new directions for AIDS vaccine, after two human trials of AIDS vaccine failed several months ago.
Genetic variations that might help people newly diagnosed with HIV control their viral loads also could be causing a mutation in the virus that makes it less potent.
In a promising new finding that could help HIV treatment, researchers in the US have discovered how a genetic circuit in HIV controls whether the virus turns on or stays dormant.
The development of new IGRA3 tests for HIV victims is based on in vitro measurement of T-cells secretion of interferon- when challenged with antigens specific to Mycobacterium tuberculosis, the bacterium causing tuberculosis
Scientists have no hope that HIV may be found in nearest future.
The anti-herpes drug acyclovir did not reduce the risk of acquiring sexually transmitted HIV.
Recent arrests and trials of HIV-positive men in Egypt are endangering human rights and fueling discrimination against people living with the disease in the country.
At 48 weeks, significantly more treatment-experienced adults with HIV-1 with documented resistance to NNRTIs and PIs had an undetectable viral load with INTELENCE tablets.
Roche and the Clinton Foundation HIV/AIDS Initiative have partnered in an effort to increase access to HIV testing among infants in 24 sub-Saharan African countries.
A lack of basic knowledge about HIV/AIDS is widespread in Singapore despite public awareness campaigns about the disease.
The President's proposed budget for fiscal year 2009, if enacted, would spell disaster for the nation's health, and by extension, our national effort to respond to the HIV/AIDS epidemic in the United States.
India's Maharashtra state will pass a law requiring HIV tests before marriage.
Papua New Guinea Business Coalition Against HIV/AIDS plans to work with businesses in the country to implement the coalition's policy on HIV/AIDS in the workplace.
The number of HIV-positive people in Vietnam with access to antiretroviral drugs increased in 2007.
UNAIDS aims to provide HIV prevention and treatment services to 80% of injection drug users in the Asia-Pacific region during the next two years.
AIDS Institute is encouraged with FDA's approval of the first new non-nucleoside reverse transcriptase inhibitor (NNRTI) in nearly a decade. TMC125/etravirine was developed by Tibotec Pharmaceuticals, Ltd. and will be marketed in the U.S. by Tibotec Therapeutics as Intelence, a division of Ortho Biotech Products, L.P. The company announced introductory pricing for the new NNRTI at $21.80 per day, which is substantially lower than other recently introduced antiretrovirals.
RNA-interference technology identified human proteins required for growth of the human immunodeficiency virus (HIV).
Jamaica's National Council on Drug Abuse to establish 10 clinics across the island that will support substance users, people living with HIV/AIDS.
Some HIV/AIDS advocates are calling on Congress to allocate more money than President Bush has asked.